Antitumor Activity of Mycobacterial Glycolipid A1

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1978 Sep 1

PMID 81809

Citations 2

Authors

Z REGGIARDO

Affiliations

Soon will be listed here.

Abstract

Glycolipid A1 isolated from Mycobacterium bovis BCG, when dissolved in olive oil and injected together with Line 10 transplantable hepatoma cells, is able to elicit a host response which results in the abrogation or retardation of tumor growth in syngeneic guinea pigs. Glycolipid A1 does not have adjuvant activity for delayed type hypersensitivity, and antibodies to A1 have not been detected in the sera of guinea pigs during or after the tumor abrogation induced by A1 injection Glycolipid A1 does not share antigenic determinants with Line 10 cell lipid fractions. The possible role of the granuloma response elicited by A1 in controlling tumor growth is discussed.

Citing Articles

Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment.

Noguera-Ortega E, Blanco-Cabra N, Rabanal R, Sanchez-Chardi A, Roldan M, Guallar-Garrido S Sci Rep. 2016; 6:27232.

PMID: 27265565 PMC: 4893706. DOI: 10.1038/srep27232.

Cerebroside sulfotransferase: preparation of antibody and localization of antigen in kidney.

Tennekoon G, Frangia J, Aitchison S, Price D J Cell Biol. 1981; 91(2 Pt 1):332-9.

PMID: 7031066 PMC: 2111977. DOI: 10.1083/jcb.91.2.332.

References

Granger D, Yamamoto K, Ribi E . Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets. J Immunol. 1976; 116(2):482-8. View

Ribi E, Granger D, MILNER K, Strain S . Tumor regression caused by endotoxins and mycobacterial fractions. J Natl Cancer Inst. 1975; 55(5):1253-7. DOI: 10.1093/jnci/55.5.1253. View

Kelly M . Plasma-dependent chemotaxis of macrophages toward BCG cell walls and the mycobacterial glycolipid P3. Infect Immun. 1977; 15(1):180-3. PMC: 421346. DOI: 10.1128/iai.15.1.180-183.1977. View

Yarkoni E, Wang L, Bekierkunst A . Stimulation of macrophages by cord factor and by heat-killed and living BCG. Infect Immun. 1977; 16(1):1-8. PMC: 421478. DOI: 10.1128/iai.16.1.1-8.1977. View

Wile A, REGGIARDO Z, Sparks F, Morton D . Monitoring immunotherapy with serologically active glycolipid fractions of BCG. Surg Forum. 1976; 27(62):105-5. View

Meyer T, Ribi E, Azuma I . Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin. Cell Immunol. 1975; 16(1):11-24. DOI: 10.1016/0008-8749(75)90181-1. View

Saito R, Tanaka A, Sugiyama K, Azuma I, Yamamura Y . Adjuvant effect of cord factor, a mycobacterial lipid. Infect Immun. 1976; 13(3):776-81. PMC: 420677. DOI: 10.1128/iai.13.3.776-781.1976. View

REGGIARDO Z, Shamsuddin A . Granulomagenic activity of serologically active glycolipids from Mycobacterium bovis BCG. Infect Immun. 1976; 14(6):1369-74. PMC: 415540. DOI: 10.1128/iai.14.6.1369-1374.1976. View

Ofek I, Bekierkunst A . Chemotactic response of leukocytes to cord factor (trehalose-6,6'-dimycolate). J Natl Cancer Inst. 1976; 57(6):1379-81. DOI: 10.1093/jnci/57.6.1379. View

10.

REGGIARDO Z, MIDDLEBROOK G . Serologically active glycolipid families from Mycobacterium bovis BCG. II. Serologic studies on human sera. Am J Epidemiol. 1974; 100(6):477-86. DOI: 10.1093/oxfordjournals.aje.a112060. View

11.

Rapp H, Churchill Jr W, KRONMAN B, Rolley R, HAMMOND W, Borsos T . Antigenicity of a new diethylnitrosamine-induced transplantable guinea pig hepatoma: pathology and formation of ascites variant. J Natl Cancer Inst. 1968; 41(1):1-7. View

12.

Zbar B, Wepsic H, Rapp H, Whang-Peng J . Transplantable hepatomas induced in strain-2 guinea pigs by diethylnitrosamine: characterization by histology, growth, and chromosomes. J Natl Cancer Inst. 1969; 43(4):821-31. View

13.

Zbar B, Tanaka T . Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis. Science. 1971; 172(3980):271-3. DOI: 10.1126/science.172.3980.271. View

14.

Zbar B, Bernstein I, Rapp H . Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin. J Natl Cancer Inst. 1971; 46(4):831-9. View

15.

Hanna Jr M, Zbar B, Rapp H . Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis. J Natl Cancer Inst. 1972; 48(5):1441-55. View

16.

Borsos T, Rapp H . Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma. J Natl Cancer Inst. 1973; 51(3):1085-6. DOI: 10.1093/jnci/51.3.1085. View

17.

Hanna Jr M, Snodgrass M, Zbar B, Rapp H . Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG. J Natl Cancer Inst. 1973; 51(6):1897-908. DOI: 10.1093/jnci/51.6.1897. View

18.

Meyer T, Ribi E, Azuma I, Zbar B . Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma. J Natl Cancer Inst. 1974; 52(1):103-11. DOI: 10.1093/jnci/52.1.103. View

19.

Bast Jr R, Zbar B, Borsos T, Rapp H . BCG and cancer (first of two parts). N Engl J Med. 1974; 290(25):1413-20. DOI: 10.1056/NEJM197406202902506. View

20.

REGGIARDO Z, MIDDLEBROOK G . Serologically active glycolipid families from Mycobacterium bovis BCG. I. Extraction, purification and immunologic studies. Am J Epidemiol. 1974; 100(6):469-76. DOI: 10.1093/oxfordjournals.aje.a112059. View